新型冠狀病毒

UK set for Covid-19 vaccinations from ‘next week’ after regulatory approval

Emergency use of BioNTech/Pfizer jab authorised ahead of US and EU

The UK has become the first country to approve a Covid-19 vaccine following large-scale clinical trials and is set to make the shot from BioNTech and Pfizer available from “next week”.

Germany’s BioNTech and US pharma giant Pfizer said doses of the vaccine would be delivered to the UK in the coming days after the UK’s Medicines and Healthcare products Regulatory Agency gave the go-ahead on Tuesday evening.

The vaccine is 95 per cent effective in preventing the disease, according to data released last month from the companies’ phase-3 trial, which involved more than 43,000 people.

您已閱讀24%(584字),剩餘76%(1854字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×